Brian Bengs for U.S. Senate US Inactive
Brian Bengs for Senate
⚠ Creative removed by Meta
This ad's image was taken down for violating Meta's ad standards; the copy below is preserved from the Ad Library.
This ad's image was taken down for violating Meta's ad standards; the copy below is preserved from the Ad Library.
Ad copy
John Thune took $2500 from insulin manufacturer Eli Lilly on August 2nd. Five days later, he voted against the $35 cap on insulin prices. On September 22nd, he received yet another $2500 from Eli Lilly. I can assure you that my votes will never be bought.
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 38.2/100 |
| Spend / Reach / Long. / Eff. | 21.0 · 61.7 · 5.8 · 64.4 |
| Spend range | USD 300–399 |
| Impressions | 20,000 – 24,999 |
| CPM (≈ $/1k impr) | USD 15.53 |
| Est. audience size | 100,001 – 500,000 |
| Days live | 22 (2022-10-17 → 2022-11-08) |
| Created | 2022-10-17 |
| Creative variants | 1 body · 0 headline |
| Platforms | |
| Languages | en |
| Candidate | SD — Brian Bengs |
| Surfaced by | “senate:Brian Bengs” |
🧠 AI analysis
| Issue | healthcare |
| Framing | attack opponent |
| Message type | persuasion |
| Emotional appeal | anger |
| Production tier | unknown |
| Who pictured | none |
| Symbols | none |
| Call to action | none |
| Standout element | Facebook content-removal notice replacing the actual ad, exposing a disclaimer compliance failure |
| Tactic | The ad copy uses a specific dollar-amount-to-vote quid pro quo narrative against Thune on insulin pricing, but the ad was pulled for disclaimer violations, making the removal notice itself the only visible content. |
Where it ran (delivery by region)
| South Dakota | 99.8% |
| Nebraska | 0.1% |
| Iowa | 0.0% |
| Minnesota | 0.0% |
| Wyoming | 0.0% |
Who saw it (delivery)
| 18-24 · unknown | 0.0% |
| 35-44 · male | 7.1% |
| 35-44 · unknown | 0.1% |
| 55-64 · female | 13.1% |
| 25-34 · male | 4.8% |
| 25-34 · female | 7.0% |
| 45-54 · female | 9.8% |
| 25-34 · unknown | 0.1% |
| 35-44 · female | 9.5% |
| 55-64 · unknown | 0.1% |
| 55-64 · male | 7.6% |
| 65+ · male | 10.3% |
| 65+ · female | 21.7% |
| 45-54 · male | 5.7% |
| 18-24 · male | 0.9% |
| 18-24 · female | 1.9% |
| 45-54 · unknown | 0.0% |
| 65+ · unknown | 0.2% |
